Xinolax DR 60 mg (Capsule (Delayed Release))
Unit Price: ৳ 16.05 (2 x 10: ৳ 321.00)
Strip Price: ৳ 160.50
Medicine Details
Category | Details |
---|---|
Generic | Duloxetine hydrochloride |
Company | Opsonin pharma ltd |
Also available as |
Indications
- Major Depressive Disorder (MDD)
- Generalized Anxiety Disorder (GAD)
- Diabetic Peripheral Neuropathic Pain (DPNP)
- Fibromyalgia
- Chronic Musculoskeletal Pain
Pharmacology
- Selective serotonin and norepinephrine reuptake inhibitor (SSNRI)
- Less potent inhibitor of dopamine reuptake
- Well absorbed through oral administration
- Metabolism mainly through hepatic metabolism
Dosage & Administration
- Starting Dose: 30 mg/day to 60 mg/day
- Target Dose: 40 mg/day to 60 mg/day
- Maximum Dose: 120 mg/day
- Some patients may benefit from starting at 30 mg once daily
- Gradual dose reduction recommended to avoid discontinuation symptoms
Interaction
- Metabolism influenced by CYP1A2 and CYP2D6 isozymes
- Potent inhibitors of CYP1A2 and CYP2D6 may increase drug concentrations
- Avoid co-administration with fluvoxamine, cimetidine, quinolone antimicrobials, and potent inhibitors of CYP2D6
Contraindications
- Known hypersensitivity to the drug or any inactive ingredients
- Not approved for treating bipolar depression
- Patients with substantial alcohol use or chronic liver disease
- Cautious use in patients with controlled narrow-angle glaucoma
Side Effects
- Nausea
- Dizziness
- Dry mouth
- Constipation
- Decreased appetite
- Fatigue
- Somnolence
- Increased sweating
- Hyperhidrosis
- Asthenia
- Slight increase in blood pressure
Pregnancy & Lactation
- Pregnancy Category C
- Use during pregnancy only if potential benefit justifies potential risk to the fetus
- Effect on labor and delivery unknown
- Not recommended for nursing mothers
Precautions & Warnings
- Close monitoring for clinical worsening and unusual changes in behavior
- Blood pressure measurement prior to treatment and periodically throughout
- Caution about the risk of bleeding when used with NSAIDs, aspirin, or other coagulation-affecting drugs
- Careful use in patients with a history of mania or seizure disorder
Use in Special Populations
- Safety and efficacy in pediatric patients not established
Overdose Effects
- Limited clinical experience with overdose in humans
- No specific antidote available
- General overdose management measures should be employed
Therapeutic Class
- Serotonin-norepinephrine reuptake inhibitor (SNRI)
Storage Conditions
- Do not store above 30°C
- Keep away from light
- Keep out of the reach of children
Related Brands
- Loxetine 20 mg (Tablet (Delayed Release)) - aci-limited
- Loxetine 30 mg (Tablet (Delayed Release)) - aci-limited
- Stresin 30 mg (Capsule (Delayed Release)) - unimed-unihealth-pharmaceuticals-ltd
- Deloxi 20 mg (Capsule (Delayed Release)) - eskayef-pharmaceuticals-ltd
- Deloxi 60 mg (Capsule (Delayed Release)) - eskayef-pharmaceuticals-ltd